47th ANNUAL NANOS MEETING
Monday, February 22, 2021     8:30 am - 10:00 am
SCIENTIFIC PLATFORM PRESENTATIONS: SESSION I
Moderators: Nagham Al-Zubidi, MD and Ruth Huna-Baron, MD

Platform presentations are chosen from submitted abstracts and will expose the audience to a wide spectrum of investigative work in the field.

Platform Presentations should be rated as a group. However, comments concerning individual presentations are welcome.

Stacy L. Pineles, MD - Two-Year Follow-Up of the Prospective Outcomes Study of Pediatric Optic Neuritis
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Scott N Grossman, MD - The MICK (Mobile Integrated Cognitive Kit) App: Digital Rapid Automatized Naming for Diagnosis of mTBI
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Raymond S. Douglas, MD, PhD - Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study Results
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Anthony Larson, BS - Frequency of Carotid Intraplaque Herorrhage on Vessel Wall Imaging in Patients with Retinal Artery Occlusion
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Wesley Chan, MD, MSc - Acute Central Retinal Artery Occlusion Seen Within 24 Hours at a Tertiary Stroke Center
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Neringa Jurkute, MD, FEBO - Neurodevelopmental Ocular Phenotype Recapitulated in a Mutant Mouse Model
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Aubrey C. Hargrave, PhD - Decreased Vision in Multiple Sclerosis is Associated with Novel Foveal Visualized Using Adaptive Optics
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.





Overall Session Questions
1. Information presented by the speakers was relevant to my practice.


2. I will make changes in my practice as a result of what I learned from the speakers.


3. Did the speakers properly disclose their financial interests? (If no, please comment)




4. Were the presentations clear of commercial bias? (If no, please comment)







Monday, February 22, 2021  10:15 am - 12:15 pm
TBI AND THE NEURO-OPHTHALMOLOGIST
Moderators: Laura Balcer, MD, MSCE and Courtney Francis, MD


Upon completion of this session, participants should be able to: (1) utilize increased knowledge of the most common afferent and efferent neuro-ophthalmologic signs and symptoms of TBI, (2) use history and examination skills to capture symptoms and signs associated with dizziness in TBI, and (3) demonstrate improved awareness and use of rehabilitation techniques for treatment of neuroophthalmologic signs and symptoms of TBI.

James Kelly, MD - Mechanism, Diagnosis and Classification of TBI
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Randy Kardon, MD, PhD - Afferent Symptoms and Signs
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Janet Rucker, MD - Efferent Symptoms and Signs
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Daniel Gold, DO - Dizziness and TBI: What’s the Connection?
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




James Kelly, MD - TBI Rehabilitation
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Craig Smith, MD - Medicolegal Issues in TBI
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.





Overall Session Questions
1. Information presented by the speakers was relevant to my practice.


2. I will make changes in my practice as a result of what I learned from the speakers.


3. Did the speakers properly disclose their financial interests? (If no, please comment)




4. Were the presentation clear of commercial bias? (If no, please comment)




Did this program meet the stated learning objectives?





Monday, February 22, 2021  12:45 pm - 2:15 pm
SCIENTIFIC PLATFORM PRESENTATIONS: SESSION II
Moderators: Susan Mollan, FRCOphth and Kenneth Shindler, MD, PhD

Platform presentations are chosen from submitted abstracts and will expose the audience to a wide spectrum of investigative work in the field.

Platform Presentations should be rated as a group. However, comments concerning individual presentations are welcome.

Matthew R. Cavanaugh, PhD - Efficacy of Visual Retraining in Hemianopic Fields After Stroke: Results of a Randomized Clinical Trial
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Michael James Gilhooley, MA, MB, Bchir, PhD, FRCOphth - Ectopic Melanopsin for Visual Restoration: Compressed Cell-Specific Promotors - a Translatable Delivery Mechanism
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Nancy J. Newman, MD - Assessment of rAAV2/2-ND4 Gene Therapy Efficacy in LHON Using an External Control Group
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Giulia Amore, MD - Leber's Hereditary Optic Neuropathy in Women
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Leanne Stunkel, MD - Patient Harm from Diagnostic Error of Neuro-Ophthalmologic Conditions
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Benjamin I. Meyer, BS - Significance of Incidental Imaging Signs of Intracranial Hypertension with Corresponding Fundus Photography: A Prospective Study
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




John J. Chen, MD, PhD - Masked Analysis of the Clinical Utility of Commercially Available Antiretinal and Anti-Optic Nerve Antibody Testing
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.





Overall Session Questions
1. Information presented by the speakers was relevant to my practice.


2. I will make changes in my practice as a result of what I learned from the speakers.


3. Did the speakers properly disclose their financial interests? (If no, please comment)




4. Were the presentations clear of commercial bias? (If no, please comment)